Evaluation of safety and efficacy of tenofovir disoproxil in hemodialysis and renal transplant patients monoinfected with hepatitis B virus based on real life data.

Akyüz F., Çavuş B., Nizam N., Göktürk S., Baran B., Yazıcı H., ...More

Clinical and experimental hepatology, vol.8, no.1, pp.7-13, 2022 (Peer-Reviewed Journal) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 8 Issue: 1
  • Publication Date: 2022
  • Doi Number: 10.5114/ceh.2022.114153
  • Journal Name: Clinical and experimental hepatology
  • Page Numbers: pp.7-13
  • Keywords: safety, tenofovir, renal transplantation, hemodialysis, chronic hepatitis B, FUMARATE, ALAFENAMIDE, PHARMACOKINETICS, DYSFUNCTION, THERAPY
  • Istanbul University Affiliated: Yes


Introduction: There are limited data about the safety of tenofovir disoproxil fumarate (TDF) in chronic renal failure (CRF). In this study, we aimed to evaluate the safety and efficacy of TDF in renal transplant recipients and hemodialysis patients with chronic hepatitis B (CHB) during long-term follow-up.